WHO’s new global guidance helps clinicians manage dengue, Zika, chikungunya, and yellow fever with protocols for fluids, ...

Patient safety means healthcare sets a particularly high standard for AI integration but the sector is increasingly ...

Panelists discuss how implementing combination immunotherapy in clinical practice faces institutional barriers, including ...

The efficacy of ruxolitinib cream in pediatric patients shows that nonsteroidal management of atopic dermatitis is feasible, ...

Eli Lilly's biggest growth driver, tirzepatide, will continue facing scrutiny from investors and analysts. The company's oral ...

Healthcare offers diverse career paths beyond traditional clinical roles like doctors and nurses. Opportunities abound in ...

A global survey of scientists and informaticians reveals growing AI investment across the biopharma value chain, but ...

Eupraxia Pharmaceuticals Inc. ('Eupraxia” or the 'Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company ...

Medpace has historically maintained a conservative balance sheet. At year-end 2024, cash and cash equivalents totaled $669 million. Medpace generated nearly $191 million in cash flow from operating ...

A chorus of honking cars during Thursday’s rush hour on Caton Avenue signaled support for registered nurses at Baltimore’s ...

Novo Nordisk's recent financial results and clinical progress haven't impressed Wall Street. Investors looking to strike while the iron is hot can buy beaten-down stocks that appear to have excellent ...

Pfizer and Novo Nordisk have underperformed the market over the past year. Pharmaceutical giants Pfizer (NYSE: PFE) and Novo ...